← Back to guidelines
Dermatology21 papers

Eccrine porocarcinoma

Last edited: 4/14/2026

Overview

Eccrine porocarcinoma is a rare, aggressive malignant tumor arising from eccrine sweat gland ducts, often developing from pre-existing benign porokeratotic conditions like porokeratosis ptychotropica. 1

Diagnosis

  • Characterized by atypical cells within cornifying horny layer of porokeratotic lesions.
  • Requires histopathological examination for definitive diagnosis.
  • Risk of malignant transformation noted in rare cases, approximately 1.7% in porokeratosis ptychotropica 1.
  • Management

  • First-line treatments: Surgical excision with clear margins is recommended for localized disease.
  • Adjunctive treatments: Topical lovastatin/cholesterol cream shows promise in managing precursor lesions 1.
  • Adjuvant therapies: Radiation and chemotherapy may be considered for advanced or metastatic disease, though specific regimens are not detailed in provided abstracts.
  • Special Populations

  • Pediatrics: Unusual presentations can occur, as seen in a case of generalized linear porokeratosis in an 8-year-old 3.
  • Elderly: No specific considerations mentioned in the abstracts.
  • Comorbidities: No specific management adjustments noted for comorbidities in the provided sources.
  • Key Recommendations

  • Long-term surveillance is prudent for patients with porokeratotic conditions due to the potential risk of malignant transformation 1 (Evidence: Moderate).
  • Consider surgical excision with clear margins for localized eccrine porocarcinoma 1 (Evidence: Expert opinion).
  • Topical lovastatin/cholesterol cream may be used for managing precursor lesions of porokeratosis 1 (Evidence: Weak).
  • References

    1 Loh CH, Tan CL, Tan KB, Sudhoff H, Goon P. Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review. Acta dermato-venereologica 2024. link 2 Okuno S, Hashimoto T, Sugiura R, Satoh T. Possible Association of Interleukin-31/-31RA Signalling and Basophils with Itch in Porokeratosis. Acta dermato-venereologica 2023. link 3 Yadav P, Sanke S, Mendiratta V, Chander R. Generalized Linear Porokeratosis in a Bilateral Distribution: An Unusual Presentation. Skinmed 2022. link 4 Happle R. Mibelli revisited: a case of type 2 segmental porokeratosis from 1893. Journal of the American Academy of Dermatology 2010. link

    Original source

    1. [1]
      Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.Loh CH, Tan CL, Tan KB, Sudhoff H, Goon P Acta dermato-venereologica (2024)
    2. [2]
      Possible Association of Interleukin-31/-31RA Signalling and Basophils with Itch in Porokeratosis.Okuno S, Hashimoto T, Sugiura R, Satoh T Acta dermato-venereologica (2023)
    3. [3]
      Generalized Linear Porokeratosis in a Bilateral Distribution: An Unusual Presentation.Yadav P, Sanke S, Mendiratta V, Chander R Skinmed (2022)
    4. [4]
      Mibelli revisited: a case of type 2 segmental porokeratosis from 1893.Happle R Journal of the American Academy of Dermatology (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG